AC Immune SA (ACIU) Stock: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.73
-0.08 (-3.02%)
âŧ
5d:
+8.13%
30d:
-4.05%
90d:
+8.57%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ACIU is fairly priced but lacks strong directional signals. At -22.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ACIU is fairly priced but lacks strong directional signals. At -22.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.27
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.13
46.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.73, which is considered fair relative to its 30-day fair value range of $2.62 to $2.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.5) compared to its historical average (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 22.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a uptrend. Immediate support is located at $2.40, while resistance sits at $2.91. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: ACIU scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.57 (+214.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACIU is in a uptrend. Immediate support is located at $2.40, while resistance sits at $2.91. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: ACIU scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.57 (+214.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.62 -
$2.82
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 214.4% below Wall St target ($8.57)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.62 -
$2.82
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.41
Resistance Level
$2.91
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.50
Wall Street Target
$8.57
(+214.4%)
Revenue Growth (YoY)
1057.2%
Profit Margin
-246.5%
Valuation Discount vs History
-22.8% cheaper
PE vs Historical
5.5 vs 11.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-22.8%
(market-implied from PE analysis)
1-Year Target
$2.45
(-10%)
2-Year Target
$2.21
(-19%)
3-Year Target
$1.99
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6â12)
$4.30
(+58%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.5 to 11.9
Stabilization Target:
$5.90
(+116.5%)
PE Expansion Potential:
+116.5%
Share & Embed Analysis
Last updated: October 03, 2026 1:14 PM ET
Data refreshes hourly during market hours. Next update: 2:14 PM
Data refreshes hourly during market hours. Next update: 2:14 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
